Universal Time: 02:47  |  Local Time: 02:47 (0h GMT)
Select your timezone:

412 - Oral Abstracts Session
Cell and Novel Therapies

Tuesday September 15, 2020 | 23:30 to 00:15
Room: Channel 8
Track: Transplant Immunosuppression

Video is available - Log in to view. You must be registered to the event to view content

Please note that Yeqi Nian may not be available for the Q&A Discussion.

Presentations

Mrs. Juan Zhang, People's Republic of China
Human mesenchymal-stem-cells derived exosomes play important roles in enhancing CB-treg suvival and functional stability

Björn Nashan, Germany
Phase 2 study design evaluating efficacy, safety, pharmacokinetics and pharmacodynamics of the anti-CD40 monoclonal antibody CFZ533 (iscalimab) in de novo liver transplant recipients: The CONTRAIL I study

Dr. Yeqi Nian, People's Republic of China
Targeting CD4+ T cell metabolism provides an effective and age-specific immunosuppression

Joseph R. Leventhal, United States
Long-term follow-up of a phase 2 clinical trial to induce tolerance in living donor renal transplant recipients

Ask a question or make a comment
This will appear in the session question feed in the dashboard

There are no comments yet...

WebApp Sponsor

© 2021 TTS 2020